Nihon Chemical Research KK header image

Nihon Chemical Research KK

4552

Equity

ISIN JP3701000006 / Valor 785030

Tokyo Stock Exchange (2024-11-21)
JPY 696.00+9.09%

Nihon Chemical Research KK
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Nihon Chemical Research KK specializes in the development, manufacturing, and sale of chemical products and materials.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (14.08.2024):

Net Sales Increase

Nihon Chemical Research KK reported a 2.1% year-over-year increase in net sales for the year ended March 31, 2023. This growth was primarily driven by revisions to selling prices, despite a challenging economic environment marked by rising raw material and fuel prices, and the weakening of the yen.

Operating Profit Decline

Despite the increase in net sales, Nihon Chemical Research KK experienced a significant 67.0% decrease in operating profit for the same period. The decline was attributed to reduced capacity utilization due to rapid production adjustments by major customers.

Segment Performance

In the Inorganic Chemicals segment, net sales increased by 26.2% year-over-year, driven by strong performance in chromium compounds and inorganic phosphorus compounds. However, the Specialty Chemicals segment saw an 8.3% decline in net sales, impacted by weak demand in certain product categories.

Capital Investments

Nihon Chemical Research KK made substantial capital investments in its Specialty Chemicals division. Notable projects include the construction of facilities for dielectric materials for MLCC at the Tokuyama Factory, expected to be completed in FY 2024, and high-purity red phosphorus for semiconductors at the Fukushima No. 2 Factory, completed in May 2022.

Future Outlook

For the year ending March 31, 2024, Nihon Chemical Research KK forecasts a 5.1% increase in net sales and a 23.8% rise in operating profit. The company anticipates a slow recovery in demand for LCDs, semiconductors, and communication products, while continuing to invest in growth areas such as electronic ceramic materials for automobiles.

Summarized from source with an LLMView Source

Key figures

-45.0%1Y
-73.5%3Y
-69.8%5Y

Performance

43.6%1Y
43.4%3Y
42.5%5Y

Volatility

Market cap

583 M

Market cap (USD)

Daily traded volume (Shares)

878,800

Daily traded volume (Shares)

1 day high/low

707 / 640

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Bright Horizons Family Solutions
Bright Horizons Family Solutions Bright Horizons Family Solutions Valor: 19920287
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.48%USD 111.05
Coty Inc
Coty Inc Coty Inc Valor: 1645885
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.70%USD 7.19
Hims & Hers Health Inc
Hims & Hers Health Inc Hims & Hers Health Inc Valor: 59397181
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
10.83%USD 24.15
Haemonetics Corp
Haemonetics Corp Haemonetics Corp Valor: 937449
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.60%USD 85.43
Perrigo Company PLC
Perrigo Company PLC Perrigo Company PLC Valor: 22008864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.26%USD 27.08
Envista Holdings Corporation
Envista Holdings Corporation Envista Holdings Corporation Valor: 49153522
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.01%USD 21.39
Biohaven Research Ltd
Biohaven Research Ltd Biohaven Research Ltd Valor: 121902526
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.50%USD 45.19
Amgen Inc
Amgen Inc Amgen Inc Valor: 907582
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.60%USD 294.53
Sanofi SA
Sanofi SA Sanofi SA Valor: 1447201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.63%USD 48.28
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.54%USD 82.44